These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 5853161)

  • 1. The ammonia tolerance test: an index of portal hypertension.
    Castell DO
    Gastroenterology; 1965 Nov; 49(5):539-43. PubMed ID: 5853161
    [No Abstract]   [Full Text] [Related]  

  • 2. [Prevention and therapy of portosystemic encephalopathy].
    Schmid M
    Schweiz Rundsch Med Prax; 1985 Sep; 74(36):954-7. PubMed ID: 2867591
    [No Abstract]   [Full Text] [Related]  

  • 3. A simple method for the quantification of portosystemic shunting (PSS) in patients with portal hypertension.
    Bödvarsson A; Verdegaal WP; Slaats EH; Geraedts AA; Kehrer DF; Silberbusch J
    Neth J Med; 1993 Dec; 43(5-6):204-9. PubMed ID: 8107925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hemodynamics in patients with liver cirrhosis and portal hypertension syndrome].
    Ershov IuA; Pomelova LA; Kulagina TV; Kislukhin VV; Morozov VA
    Sov Med; 1984; (7):17-23. PubMed ID: 6484727
    [No Abstract]   [Full Text] [Related]  

  • 5. [Hemodynamic changes and its significance after liver transplantation for cirrhosis and portal hypertension].
    Zhang TL
    Zhonghua Wai Ke Za Zhi; 2008 Nov; 46(22):1689-92. PubMed ID: 19094724
    [No Abstract]   [Full Text] [Related]  

  • 6. [The ammonia tolerance test in intra- and extrahepatic portal vein block].
    Ziegler K
    Dtsch Z Verdau Stoffwechselkr; 1968; 28(2):229-32. PubMed ID: 5732402
    [No Abstract]   [Full Text] [Related]  

  • 7. [Hemodynamics evaluation of the cirrhotic patient with portal hypertension].
    Morales Méndez S; Bernardos Rodríguez A; Salvador-Almeida Reyes D; Tutosaus Gómez JD
    Rev Esp Enferm Apar Dig; 1980 Nov; 58(5):497-504. PubMed ID: 7465961
    [No Abstract]   [Full Text] [Related]  

  • 8. Small intestinal motility disturbances and bacterial overgrowth in patients with liver cirrhosis and portal hypertension.
    Gunnarsdottir SA; Sadik R; Shev S; Simrén M; Sjövall H; Stotzer PO; Abrahamsson H; Olsson R; Björnsson ES
    Am J Gastroenterol; 2003 Jun; 98(6):1362-70. PubMed ID: 12818282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic haemodynamics in cirrhosis and portal hypertension with focus on vasoactive substances and prognosis.
    Møller S
    Dan Med Bull; 1998 Feb; 45(1):1-14. PubMed ID: 9504263
    [No Abstract]   [Full Text] [Related]  

  • 10. Vasoactive factors and hemodynamic mechanisms in the pathophysiology of portal hypertension in cirrhosis.
    Gatta A; Bolognesi M; Merkel C
    Mol Aspects Med; 2008; 29(1-2):119-29. PubMed ID: 18036654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hemodynamic studies in patients with hepatic cirrhosis and portal hypertension].
    Tan YQ
    Zhonghua Wai Ke Za Zhi; 1983 May; 21(5):278-80. PubMed ID: 6628111
    [No Abstract]   [Full Text] [Related]  

  • 12. [Cirrhosis of the liver without portal hypertension (author's transl)].
    Cortinovis A; Crippa A; Bellorini R
    Chir Ital; 1980 Oct; 32(5):996-1005. PubMed ID: 7249193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic hemodynamic changes in portal hypertension.
    Ready J; Rector WG
    Semin Gastrointest Dis; 1995 Jul; 6(3):134-9. PubMed ID: 7551970
    [No Abstract]   [Full Text] [Related]  

  • 14. The paradox of nitric oxide in cirrhosis and portal hypertension: too much, not enough.
    Wiest R; Groszmann RJ
    Hepatology; 2002 Feb; 35(2):478-91. PubMed ID: 11826425
    [No Abstract]   [Full Text] [Related]  

  • 15. Autonomic dysfunction in cirrhosis and portal hypertension.
    Dümcke CW; Møller S
    Scand J Clin Lab Invest; 2008; 68(6):437-47. PubMed ID: 18609092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The characteristics of the surgical procedure in treating subcompensated portal hypertension in liver cirrhosis].
    Nazyrov FG; Vakhidov AV; Deviatov AV; Akilov KhA; Mansurov AA
    Vestn Khir Im I I Grek; 1992; 149(11-12):318-22. PubMed ID: 8594788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Physiopathologic basis of medical therapy of portal hypertension in cirrhosis].
    Gatta A; Bolognesi M; Sacerdoti D; Merkel C
    Ann Ital Med Int; 1996 Oct; 11 Suppl 2():39S-47S. PubMed ID: 9004819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Physiopathological bases of the medical treatment of portal hypertension].
    Cuccurullo F; Seccia G; Porreca E; Guglielmi MD; Mezzetti A; Tomassetti V; Marzio L
    G Clin Med; 1982 Oct; 63(10):737-43. PubMed ID: 7182198
    [No Abstract]   [Full Text] [Related]  

  • 19. [Gallbladder contractile function in patients with portal hypertension].
    Zhu JF
    Zhonghua Wai Ke Za Zhi; 1993 Jan; 31(1):34-6. PubMed ID: 8404340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interorgan ammonia and amino acid metabolism in metabolically stable patients with cirrhosis and a TIPSS.
    Olde Damink SW; Jalan R; Redhead DN; Hayes PC; Deutz NE; Soeters PB
    Hepatology; 2002 Nov; 36(5):1163-71. PubMed ID: 12395326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.